Showing 1,301 - 1,320 results of 113,108 for search '(( 12 m decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.89s Refine Results
  1. 1301

    The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

    Published 2017
    “…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”
  2. 1302
  3. 1303
  4. 1304
  5. 1305
  6. 1306
  7. 1307

    Optogenetic Recruitment of Dorsal Raphe Serotonergic Neurons Acutely Decreases Mechanosensory Responsivity in Behaving Mice by Guillaume P. Dugué (620333)

    Published 2014
    “…<i>In vivo</i>, the photoactivation of dorsal raphe serotonergic neurons gave rise to a prominent light-evoked field response that displayed some sensitivity to a 5-HT1A agonist, consistent with autoreceptor inhibition of raphe neurons. …”
  8. 1308

    Specific inhibition of ATG5 and ATG7 decrease low glucose-induced LC3-II accumulation. by Delphine Balmer (458897)

    Published 2013
    “…<p>Lentiviruses expressing specific shRNA were used to decrease the expression of ATG5 and ATG7 as described in material & methods, then each clonal cell colony was treated and cultured as mentioned in material & methods. …”
  9. 1309
  10. 1310
  11. 1311

    Decreases in time from AHP to threshold account for increased firing of cPLA<sub>2</sub>α<sup>-/-</sup> SCG neurons. by Liwang Liu (424650)

    Published 2018
    “…<p>(<b>A-B)</b> Examples of differences in AP firing during a 1 sec injection of 100 pA of current. …”
  12. 1312
  13. 1313
  14. 1314
  15. 1315
  16. 1316
  17. 1317
  18. 1318
  19. 1319
  20. 1320

    Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

    Published 2022
    “…Interestingly, <b>4f</b> showed remarkable PI3K/AKT/mTOR inhibitory activity with 0.18-, 0.27-, and 0.39-fold decrease in their concentration (reduction in controls from 6.64, 45.39, and 86.39 ng/mL to 1.24, 12.35, and 34.36 ng/mL, respectively). …”